Cardlytics, Inc. (CDLX) is a Advertising Agencies company in the Communication Services sector, currently trading at $0.97. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
Analyst consensus target is CDLX = $1 (+3.5% upside).
Valuation: CDLX trades at a trailing Price-to-Earnings (P/E) of -0.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.01.
Financials: revenue is $233M, -7.5%/yr average growth. Net income is $103M (loss), growing at +25.3%/yr. Net profit margin is -44.4% (negative). Gross margin is 45% (+7.3 pp trend).
Balance sheet: total debt is $215M with negative equity of -$7M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 1.75 (strong liquidity). Debt-to-assets is 75.4%. Total assets: $286M.
Analyst outlook: 4 / 15 analysts rate CDLX as buy (27%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 79/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 51/100 (Partial), Future 34/100 (Fail), Income 10/100 (Fail).
